Comparative safety of biologic versus conventional synthetic DMARDs in rheumatoid arthritis with COPD: a real-world population study

OBJECTIVES: Abatacept, a biologic DMARD, was associated with respiratory adverse events in a small subgroup of RA patients with chronic obstructive pulmonary disease (COPD) in a trial. Whether this potential risk is specific to abatacept or extends to all biologics and targeted synthetic DMARDs (tsD...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Rheumatology (Oxford)
Autores principales: Hudson, Marie, Dell’Aniello, Sophie, Shen, Sophie, Simon, Teresa A, Ernst, Pierre, Suissa, Samy
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Clinical Science
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7188346/
https://ncbi.nlm.nih.gov/pubmed/31504972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kez359
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares